{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:46:28Z","timestamp":1781945188259,"version":"3.54.5"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113025","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T12:19:15Z","timestamp":1651493955000},"page":"113025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review"],"prefix":"10.1016","volume":"150","author":[{"given":"Rashmi","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phool","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113025_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.15537\/1658-3175.1664","article-title":"History of diabetes mellitus","volume":"23","author":"Ahmed","year":"2002","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.biopha.2022.113025_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncpneuro0504","article-title":"Diabetic neuropathy--a review","volume":"3","author":"Said","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/149452","article-title":"Animal models of diabetic neuropathy: progress since 1960s","volume":"2013","author":"Islam","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2022.113025_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2022.113025_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11062-020-09865-2","article-title":"Etiological aspects for the occurrence of diabetic neuropathy and the suggested measures","volume":"52","author":"Grover","year":"2020","journal-title":"Neurophysiology"},{"key":"10.1016\/j.biopha.2022.113025_bib6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S1734-1140(13)71521-4","article-title":"Mechanisms and pharmacology of diabetic neuropathy \u2013 experimental and clinical studies","volume":"65","author":"Zychowska","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2022.113025_bib7","series-title":"Diabetic Neuropathy: Clinical Management","first-page":"275","article-title":"Clinical diagnosis of diabetic neuropathy","author":"Skljarevski","year":"2007"},{"key":"10.1016\/j.biopha.2022.113025_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib9","series-title":"The World Health Report 2002: Reducing Risks, Promoting Healthy Life","author":"Organization","year":"2002"},{"key":"10.1016\/j.biopha.2022.113025_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/dc17-2062","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: addition-Denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/acn3.531","article-title":"Diabetes and obesity are the main metabolic drivers of peripheral neuropathy","volume":"5","author":"Callaghan","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/jnnp-2016-314171","article-title":"Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2022.113025_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc18-1842","article-title":"General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4\/FF4 Cohort","volume":"42","author":"Schlesinger","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib16","article-title":"Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS)","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113025_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.410350509","article-title":"Nerve biopsy findings in different patterns of proximal diabetic neuropathy","volume":"35","author":"Said","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","article-title":"The spectrum of diabetic neuropathies","volume":"19","author":"Tracy","year":"2008","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.biopha.2022.113025_bib19","first-page":"1","article-title":"Diabetic neuropathy: a clinical and histological study on the significance of vascular affections","volume":"345","author":"Fagerberg","year":"1959","journal-title":"Acta Med. Scand. Suppl."},{"key":"10.1016\/j.biopha.2022.113025_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113025_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/jnnp.40.11.1072","article-title":"Nerve biopsy and conduction studies in diabetic neuropathy","volume":"40","author":"Behse","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2022.113025_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/92.2.391","article-title":"The pathogenesis of sural nerve changes in diabetes mellitus","volume":"92","author":"Chopra","year":"1969","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2022.113025_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410190503","article-title":"Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005072-199307000-00003","article-title":"Ultrastructural morphometric features of human sural nerve endoneurial microvessels","volume":"52","author":"Giannini","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00685323","article-title":"[Ultrastructural study of pheripheral nerve in 16 diabetics without neuropathy. Comparisons with 16 diabetic neuropathies and 16 non-diabetic neuropathies (author\u2019s transl)]","volume":"30","author":"Vital","year":"1974","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2022.113025_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archneur.1976.00500030020004","article-title":"Painful diabetic neuropathy: a morphometric study","volume":"33","author":"Brown","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/jcp.38.9.1030","article-title":"Small vessel disease in progressive diabetic neuropathy associated with good metabolic control","volume":"38","author":"Timperley","year":"1985","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2022.113025_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jcp.33.5.462","article-title":"Electron microscopical studies of vessels in diabetic peripheral neuropathy","volume":"33","author":"Williams","year":"1980","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2022.113025_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s001250051063","article-title":"The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS)","volume":"41","author":"Cabezas-Cerrato","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1464-5491.2002.00819.x","article-title":"Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score","volume":"19","author":"Meijer","year":"2002","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpainsymman.2004.06.018","article-title":"Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy","volume":"29","author":"Zelman","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.biopha.2022.113025_bib32","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00024677-200302060-00003","article-title":"Current and future strategies for the management of diabetic neuropathy","volume":"2","author":"Malik","year":"2003","journal-title":"Treat Endocrinol."},{"key":"10.1016\/j.biopha.2022.113025_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2022.113025_bib35","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/diacare.26.9.2549","article-title":"The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument","volume":"26","author":"Vileikyte","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2022.113025_bib37","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1210\/en.2009-1342","article-title":"New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}","volume":"151","author":"Drel","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.113025_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/157488411798375967","article-title":"Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control","volume":"6","author":"Miranda-Massari","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10286-010-0062-x","article-title":"Cardiovascular autonomic neuropathy and other complications in type 1 diabetes","volume":"20","author":"Pavy-Le Traon","year":"2010","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.biopha.2022.113025_bib40","doi-asserted-by":"crossref","unstructured":"Oates PJJ Iron. Polyol pathway and diabetic peripheral neuropathy 50 (2002) 325\u2013392.","DOI":"10.1016\/S0074-7742(02)50082-9"},{"key":"10.1016\/j.biopha.2022.113025_bib41","first-page":"255","article-title":"Enhancement of reactive oxygen species and induction of apoptosis in streptozotocin-induced diabetic rats under hyperbaric oxygen exposure","volume":"4","author":"Matsunami","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2022.113025_bib42","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1210\/en.2009-1342","article-title":"New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-\u03b1","volume":"151","author":"Drel","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.113025_bib43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/diab.28.6.604","article-title":"Diabetic neuropathy--new concepts of its etiology","volume":"28","author":"Clements","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0074-7742(02)50072-6","article-title":"Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options","volume":"50","author":"Thornalley","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2022.113025_bib45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2337\/diab.32.7.670","article-title":"Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats","volume":"32","author":"Vlassara","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib46","doi-asserted-by":"crossref","first-page":"31038","DOI":"10.1074\/jbc.M704703200","article-title":"High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A","volume":"282","author":"Yao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113025_bib47","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/mnfr.200700008","article-title":"Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts","volume":"51","author":"Ramasamy","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2022.113025_bib48","doi-asserted-by":"crossref","first-page":"16r","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.biopha.2022.113025_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2006-0073","article-title":"Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress","volume":"148","author":"Vincent","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.113025_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.113025_bib51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/db07-0339","article-title":"Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy","volume":"57","author":"Toth","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib52","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1196\/annals.1338.067","article-title":"Role of advanced glycation end products and their receptors in development of diabetic neuropathy","volume":"1043","author":"Wada","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2022.113025_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2009.09.030","article-title":"Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain","volume":"623","author":"Mika","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/glia.20623","article-title":"Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling","volume":"56","author":"Tsuda","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2022.113025_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","article-title":"Norman Cousins Lecture. Glia as the \u201cbad guys\u201d: implications for improving clinical pain control and the clinical utility of opioids","volume":"21","author":"Watkins","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2022.113025_bib56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1744-8069-7-52","article-title":"Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators","volume":"7","author":"Bishnoi","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.biopha.2022.113025_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/J426v02n01_03","article-title":"Analgesic actions of insulin","volume":"2","author":"Smith","year":"2011","journal-title":"J. Neuropathic Pain Symptom Palliation"},{"key":"10.1016\/j.biopha.2022.113025_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.04.014","article-title":"Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms","volume":"661","author":"Pabreja","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157339905774574383","article-title":"The potential role of thiamine (vitamin B1) in diabetic complications","volume":"1","author":"Thornalley","year":"2005","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.biopha.2022.113025_bib60","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113025_bib61","doi-asserted-by":"crossref","first-page":"15237","DOI":"10.1074\/jbc.271.25.15237","article-title":"Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription","volume":"271","author":"Sayeski","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113025_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1172\/JCI119875","article-title":"High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells","volume":"101","author":"Kolm-Litty","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113025_bib63","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","article-title":"Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation","volume":"97","author":"Du","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113025_bib64","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1365-2362.1996.2260560.x","article-title":"Elevated serum transforming growth factor beta 1 level in primary lung cancer patients with finger clubbing","volume":"26","author":"Hirakata","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113025_bib65","doi-asserted-by":"crossref","first-page":"31099","DOI":"10.1074\/jbc.M104115200","article-title":"Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress","volume":"276","author":"Kaneto","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113025_bib66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI13038","article-title":"Can VEGF reverse diabetic neuropathy in human subjects?","volume":"107","author":"Veves","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113025_bib67","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db06-0655","article-title":"Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta\u2019s actions to normalize cardiac gene expression and fuel metabolism in diabetic rats","volume":"56","author":"Arikawa","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib68","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/diab.46.9.1497","article-title":"Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro","volume":"46","author":"Williams","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198703053161007","article-title":"Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications","volume":"316","author":"Greene","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib70","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/diabetes.48.10.2090","article-title":"A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats","volume":"48","author":"Nakamura","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib71","doi-asserted-by":"crossref","first-page":"E553","DOI":"10.1152\/ajpendo.2000.278.3.E553","article-title":"Protein kinase C modulates insulin action in human skeletal muscle","volume":"278","author":"Cortright","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113025_bib72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1570161054368634","article-title":"Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy","volume":"3","author":"Obrosova","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/0929867033368376","article-title":"Poly(ADP-ribose) polymerase inhibitors","volume":"10","author":"Southan","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113025_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83241","article-title":"Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation","volume":"7","author":"Garcia Soriano","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib75","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.052712399","article-title":"Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia","volume":"99","author":"Ha","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113025_bib76","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2337\/diabetes.54.12.3435","article-title":"Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diabetes.51.2.514","article-title":"The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes","volume":"51","author":"Pacher","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(99)00356-8","article-title":"Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy","volume":"375","author":"Greene","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib79","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1152\/ajpendo.00048.2004","article-title":"C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB\/Wor rats","volume":"287","author":"Stevens","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113025_bib80","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.2337\/db06-1176","article-title":"High-fat diet induced neuropathy of pre-diabetes and obesity: effects of \u201chealthy\u201d diet and aldose reductase inhibition","volume":"56","author":"Obrosova","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib81","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily","volume":"114","author":"Bierhaus","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113025_bib82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/156652407783220705","article-title":"RAGE, diabetes, and the nervous system","volume":"7","author":"Toth","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00400231","article-title":"Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats","volume":"36","author":"Cameron","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/diabetes.49.6.1006","article-title":"Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy","volume":"49","author":"Stevens","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib85","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ncpneuro0320","article-title":"Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy","volume":"2","author":"Leinninger","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-009-1553-y","article-title":"Diabetes regulates mitochondrial biogenesis and fission in mouse neurons","volume":"53","author":"Edwards","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib87","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1096\/fj.04-2513fje","article-title":"Short-term hyperglycemia produces oxidative damage and apoptosis in neurons","volume":"19","author":"Vincent","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.biopha.2022.113025_bib88","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db09-0034","article-title":"Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress","volume":"58","author":"Zherebitskaya","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib89","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2337\/diabetes.52.8.2129","article-title":"Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia","volume":"52","author":"Huang","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib90","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic somatic neuropathies","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib91","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/diacare.13.10.1057","article-title":"Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients","volume":"13","author":"Sosenko","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib92","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.284.17.2215","article-title":"Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group","volume":"284","author":"Apfel","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2022.113025_bib93","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.52.2.536","article-title":"Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes","volume":"52","author":"Ekberg","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113025_bib94","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"60","author":"Shy","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113025_bib95","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.phm.0000163863.85719.6e","article-title":"Under-recognition of polyneuropathy in persons with diabetes by nonphysician electrodiagnostic services providers","volume":"84","author":"Dillingham","year":"2005","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.biopha.2022.113025_bib96","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-2999(00)00227-2","article-title":"ATP-sensitive K(+) channel effects on nerve function, Na(+), K(+) ATPase, and glutathione in diabetic rats","volume":"397","author":"Hohman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib97","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.410380323","article-title":"Diabetic polyneuropathy in controlled clinical trials: Consensus Report of the Peripheral Nerve Society","volume":"38","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-122-8-199504150-00001","article-title":"The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group","volume":"122","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib99","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF00403376","article-title":"The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study","volume":"37","author":"Amthor","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib101","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1464-5491.1991.tb01530.x","article-title":"The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy","volume":"8","author":"Veves","year":"1991","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0022-510X(95)00243-U","article-title":"Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements","volume":"135","author":"Russell","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2022.113025_bib103","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113025_bib104","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"issue":"Pt 3","key":"10.1016\/j.biopha.2022.113025_bib106","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1113\/jphysiol.1996.sp021814","article-title":"Heat-evoked vasodilatation in human hairy skin: axon reflexes due to low-level activity of nociceptive afferents","volume":"497","author":"Magerl","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2022.113025_bib107","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2337\/diacare.24.2.344","article-title":"Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy","volume":"24","author":"Hamdy","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib108","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.2337\/diacare.27.12.2930","article-title":"The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes","volume":"27","author":"Krishnan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib109","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<345::AID-DIA381>3.0.CO;2-B","article-title":"Nerve biopsy","volume":"14","author":"Thomas","year":"1997","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<353::AID-DIA343>3.0.CO;2-E","article-title":"Persistent postoperative complaints after whole sural nerve biopsies in diabetic and non-diabetic subjects","volume":"14","author":"Dahlin","year":"1997","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib111","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.53.3.580","article-title":"Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group","volume":"53","author":"Greene","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113025_bib112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib113","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"McCarthy","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113025_bib114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410440111","article-title":"Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases","volume":"44","author":"Holland","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.290.10.1371","article-title":"New insights into diabetic polyneuropathy","volume":"290","author":"Polydefkis","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2022.113025_bib116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(00)05268-5","article-title":"Spinal-cord involvement in diabetic peripheral neuropathy","volume":"358","author":"Eaton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113025_bib117","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jns5.12072","article-title":"Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)","volume":"19","author":"Biessels","year":"2014","journal-title":"J. Peripher Nerv. Syst."},{"key":"10.1016\/j.biopha.2022.113025_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/149452","article-title":"Animal models of diabetic neuropathy: progress since 1960s","volume":"2013","author":"Islam","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2022.113025_bib119","first-page":"1","article-title":"Melatonin ameliorates neuropathy in diabetic rats by abating mitochondrial dysfunction and metabolic derangements","author":"Magar","year":"2020","journal-title":"Endocr. Metab. Sci."},{"key":"10.1016\/j.biopha.2022.113025_bib120","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00125-008-1136-3","article-title":"Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes","volume":"51","author":"Vareniuk","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/brb3.111","article-title":"Development of sensory neuropathy in streptozotocin-induced diabetic mice","volume":"3","author":"Murakami","year":"2013","journal-title":"Brain Behav."},{"key":"10.1016\/j.biopha.2022.113025_bib122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00260960","article-title":"Peripheral neurology of the diabetic Chinese hamster","volume":"23","author":"Kennedy","year":"1982","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113025_bib123","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aat.2011.01.003","article-title":"Antinociceptive effects of combination of tramadol and acetaminophen on painful diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"49","author":"Gong","year":"2011","journal-title":"Acta Anaesthesiol. Taiwan"},{"key":"10.1016\/j.biopha.2022.113025_bib124","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00580-009-0830-y","article-title":"Pain sensitivity in diabetic rats during estrous","volume":"19","author":"Taherianfard","year":"2009","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.biopha.2022.113025_bib125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1529-8027.2011.00345.x","article-title":"Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice","volume":"16","author":"Homs","year":"2011","journal-title":"J. Peripher Nerv. Syst."},{"key":"10.1016\/j.biopha.2022.113025_bib126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1358\/mf.2006.28.1.962772","article-title":"Physiological characteristics of diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats","volume":"28","author":"Kamenov","year":"2006","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113025_bib127","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mus.21564","article-title":"Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells","volume":"41","author":"Seraf\u00edn","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.biopha.2022.113025_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/431980","article-title":"The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy","volume":"2009","author":"Davidson","year":"2009","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.biopha.2022.113025_bib129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/CS20050330","article-title":"Lessons on autoimmune diabetes from animal models","volume":"110","author":"Yang","year":"2006","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2022.113025_bib130","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1084\/jem.20090889","article-title":"Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock","volume":"206","author":"Busik","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pharmthera.2012.11.004","article-title":"Murine models for pharmacological studies of the metabolic syndrome","volume":"137","author":"Fellmann","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.113025_bib132","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/dmrr.552","article-title":"Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies","volume":"21","author":"Adriaensen","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.biopha.2022.113025_bib133","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib134","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113025_bib135","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.2337\/dc07-0206","article-title":"Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis","volume":"30","author":"Del Carro","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113025_bib136","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib137","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00003495-200767040-00006","article-title":"Diabetic painful neuropathy: current and future treatment options","volume":"67","author":"Chong","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2022.113025_bib138","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0074-7742(02)50082-9","article-title":"Polyol pathway and diabetic peripheral neuropathy","volume":"50","author":"Oates","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2022.113025_bib139","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0753-3322(96)82642-4","article-title":"Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study","volume":"49","author":"Goto","year":"1995","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113025_bib140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040622314552071","article-title":"Treatment of painful diabetic neuropathy","volume":"6","author":"Javed","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.biopha.2022.113025_bib141","first-page":"151","article-title":"Treatment of painful diabetic neuropathy with topical capsaicin","year":"1991","journal-title":"Arch. Intern. Med."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2022.113025_bib142","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1529-8027.2012.00391.x","article-title":"Treatments for diabetic neuropathy","volume":"17","author":"Bril","year":"2012","journal-title":"J. Peripher Nerv. Syst."},{"key":"10.1016\/j.biopha.2022.113025_bib143","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archneur.61.6.914","article-title":"Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy","volume":"61","author":"Barbano","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2022.113025_bib144","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:51:52Z","timestamp":1780487512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":144,"alternative-id":["S0753332222004140"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113025","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113025"}}